The percentage of overlap for ccRCC ranges from 63% to 100% and for pRCC from 50 to 100%, suggesting that AR regulates common pathways in ccRCC and pRCC through common target genes. The gene discussed is AR; the disease is nonpapillary renal cell carcinoma.